Parametrica Management’s Zimmer Biomet ZBH Stock Holding History

Parametrica Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,326	Closed	-$207K	–	124
2021 Q2	$207K	Buy	+1,326	New	+$215K	0.15%	84
2019 Q1	–	Sell	-2,313	Closed	-$233K	–	325
2018 Q4	$233K	Buy	+2,313	New	+$260K	0.28%	192
2017 Q3	–	Sell	-2,036	Closed	-$254K	–	451
2017 Q2	$254K	Buy	+2,036	New	+$241K	0.24%	172

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Parametrica Management's ZBH Position: Q3 2021 in Review

Parametrica Management sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 1,326 shares — an estimated $207K sold.

Parametrica Management first reported a position in ZBH in Q2 2017 and held it in 3 quarters. The position peaked at $254K in Q2 2017. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

Parametrica Management reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
Parametrica Management sold 1,326 Zimmer Biomet shares in Q3 2021, an estimated $207K.
Parametrica Management first reported a position in Zimmer Biomet in Q2 2017 and held it in 3 quarters.
Parametrica Management's Zimmer Biomet position peaked at $254K in Q2 2017.
982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Parametrica Management's 13F filing for Q3 2021, filed 12 Nov 2021.